IIBBA   05544
INSTITUTO DE INVESTIGACIONES BIOQUIMICAS DE BUENOS AIRES
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
A cost-effective prophylactic HPV vaccine for massive application
Autor/es:
ALONSO LEONARDO G.
Lugar:
Buenos Aires
Reunión:
Conferencia; FAIC (First French-Argentine immunology congress); 2010
Institución organizadora:
Sociedad Argentina de Inmunologia
Resumen:
@font-face { font-family: "Times New Roman"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }table.MsoNormalTable { font-size: 10pt; font-family: "Times New Roman"; }div.Section1 { page: Section1; } @font-face { font-family: "Times New Roman"; }p.MsoNormal, li.MsoNormal, div.MsoNormal { margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: "Times New Roman"; }table.MsoNormalTable { font-size: 10pt; font-family: "Times New Roman"; }div.Section1 { page: Section1; } Virus-like particles (VLPs) are ideal vaccine candidates for numerous reasons such as immunogenicity and null infective capacity.  However, in order to produce cost-effective vaccines, the technology focus should be put on bacterialy expressed recombinant proteins.  These are almost always produced as unfolded proteins or inclusion bodies, and the challenge is to be able to fold the capsomeres and assembly the VLPs in vitro.  We present the case of HPV VLPs, where the main focus is the world population that  cannot afford a high cost vaccine.